发明名称 Use of benzodiazepines for treating autoimmune diseases, inflammations, neoplasies, viral infections and atherosclerosis
摘要 <p>Benzodiazepine compounds, and methods for using those compounds are provided. Some of the benzodiazepine compounds include 1,4-benzodiazepine-2-one and 1,4-benzodiazepine-2,5-dione compounds of structures (I) or (II): wherein R1, R2, R3 and R4 are as defined. The invention also includes enantiomers, pharmaceutically acceptable salts, prodrugs or derivatives of the benzodiazepine compounds. Any one or more of these benzodiazepine compounds can be used to treat a variety of dysregulatory disorders related to cellular death. Such disorders include autoimmune disorders, inflammatory conditions, hyperproliferative conditions, viral infections, and atherosclerosis. In addition, the above compounds can be used to prepare medicaments to treat the above-described dysregulatory disorders. The benzodiazepines can also be used in drugs screening assays and other diagnostic methods. <IMAGE></p>
申请公布号 EP1398033(B1) 申请公布日期 2009.06.17
申请号 EP20030027484 申请日期 2000.04.27
申请人 THE REGENTS OF THE UNIVERSITY OF MICHIGAN 发明人 GLICK, GARY, D.;OPIPARI, ANTHONY, W.,JR.
分类号 A61K31/5513;A61K31/55;A61K31/551;A61K45/00;A61P1/00;A61P9/10;A61P11/06;A61P15/00;A61P17/06;A61P19/02;A61P19/04;A61P21/04;A61P29/00;A61P31/12;A61P31/18;A61P31/22;A61P35/00;A61P37/00;A61P37/02;A61P37/06;C07D243/14;C07D243/24;C07D401/12;C07D403/12;C07D413/12 主分类号 A61K31/5513
代理机构 代理人
主权项
地址